Cargando…
An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia
The over-expression of the Bcl-2 protein is a common feature of many solid cancers and hematological malignancies, and it is typically associated with poor prognosis and resistance to chemotherapy. Bcl-2-specific inhibitors, such as venetoclax, have recently been approved for the treatment of chroni...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469948/ https://www.ncbi.nlm.nih.gov/pubmed/36099249 http://dx.doi.org/10.1371/journal.pcbi.1010439 |